René Bernards
2022
In 2022, René Bernards earned a total compensation of $133.9K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Other | $133,873 |
|---|---|
| Total | $133,873 |
Bernards received $133.9K in other compensation, accounting for 100% of the total pay in 2022.
Rankings
In 2022, René Bernards' compensation ranked 5,544th out of 5,760 executives tracked by ExecPay. In other words, Bernards earned more than 3.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,544 out of 5,760 | 4th |
Division Manufacturing | 3,028 out of 3,136 | 3rd |
Major group Chemicals And Allied Products | 1,385 out of 1,422 | 3rd |
Industry group Drugs | 1,292 out of 1,323 | 2nd |
Industry Pharmaceutical Preparations | 942 out of 969 | 3rd |
Source: SEC filing on November 4, 2024.
Bernards' colleagues
We found six more compensation records of executives who worked with René Bernards at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS